Skip to main content


You are here

MedImmune, UMB ink $6 million research partnership

Wednesday, September 25, 2013

Gaithersburg-based MedImmune announced on Wednesday a $6 million research partnership with the University of Maryland–Baltimore that will pool the scientific talent of both organizations.

The deal spans five years, with all but $1 million of the bill footed by MedImmune. Under the agreement — the first of several planned for the Maryland biotech firm— MedImmune and UMB will undertake joint projects in the company's "core therapeutic areas," which include oncology, autoimmune and respiratory diseases. UMB is home to the University of Maryland BioPark.

Read full article in Washington Business Journal

Read related article in Baltimore Sun